Company Overview of Dezima Pharma B.V.
Dezima Pharma B.V. develops protein-based compounds for treatment of cardiovascular disease related to dyslipidemia. The company was founded in 2012 and is based in Naarden, the Netherlands. As of October 14, 2015, Dezima Pharma B.V. operates as a subsidiary of Amgen Inc..
Naarden, 1411 DC
Founded in 2012
31 35 699 3000
31 35 699 3001
Key Executives for Dezima Pharma B.V.
Dezima Pharma B.V. Key Developments
Similar Private Companies By Industry
|ACS Biomarker B.V.||Europe|
|Agventure Exploitatie BV||Europe|
|Alloksys Life Sciences BV||Europe|
|Amarna Therapeutics B.V.||Europe|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
|The Advertising Council, Inc.||United States|
Sponsored Financial Commentaries
To contact Dezima Pharma B.V., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.